首页 | 本学科首页   官方微博 | 高级检索  
检索        

蝎毒多肽提取物促进自噬抑制S180肉瘤作用机制的研究
引用本文:张璐璐,张维东,武力存,张月英,王兆朋,王朝霞,贾青,赵嵌嵌.蝎毒多肽提取物促进自噬抑制S180肉瘤作用机制的研究[J].中草药,2015,46(8):1190-1194.
作者姓名:张璐璐  张维东  武力存  张月英  王兆朋  王朝霞  贾青  赵嵌嵌
作者单位:山东省医学科学院基础医学研究所 病理室, 山东省罕见病重点实验室, 山东 济南 250062;济南大学山东省医学科学院医学与生命科学学院, 山东 济南 250062;山东省医学科学院基础医学研究所 病理室, 山东省罕见病重点实验室, 山东 济南 250062;山东省医学科学院基础医学研究所 病理室, 山东省罕见病重点实验室, 山东 济南 250062;山东省医学科学院基础医学研究所 病理室, 山东省罕见病重点实验室, 山东 济南 250062;山东省医学科学院基础医学研究所 病理室, 山东省罕见病重点实验室, 山东 济南 250062;山东省医学科学院基础医学研究所 病理室, 山东省罕见病重点实验室, 山东 济南 250062;山东省医学科学院基础医学研究所 病理室, 山东省罕见病重点实验室, 山东 济南 250062;山东省医学科学院基础医学研究所 病理室, 山东省罕见病重点实验室, 山东 济南 250062;济南大学山东省医学科学院医学与生命科学学院, 山东 济南 250062
基金项目:国家自然科学基金资助项目(81073102,30873408);山东省自然科学基金资助项目(ZR2010HQ003);国家青年科学基金项目(81303077);国家自然科学基金青年基金项目(81403150)
摘    要:目的 探讨蝎毒多肽提取物(polypeptide extract from scorpion venom,PESV)抑制S180肉瘤的机制.方法 小鼠30只,建立S180肉瘤皮下荷瘤模型,随机分为对照组、PESV组和雷帕霉素(rapamycin,RAPA)组,每组10只,给药组ig给药,连续给药14 d.绘制肿瘤体积生长曲线并且计算抑瘤率;HE染色观察各组肿瘤组织病理变化;免疫组织化学法检测肿瘤组织中Beclin1、MAP1LC3A、CD133的蛋白表达差异;Western blotting检测各组肿瘤组织中Beclin1、MAP1LC3A、CD133的蛋白表达.结果 PESV组和RAPA组移植瘤的生长受到明显抑制,PESV组与RAPA组的抑瘤率分别为17.9%和25.0%(P< 0.05).与对照组相比,PESV组和RAPA组Beclin1、MAP1LC3A蛋白表达明显上调(P< 0.05).且CD133的蛋白表达明显下调(P< 0.01).结论 PESV可抑制S180肉瘤细胞生长,其机制可能与促进自噬相关因子Beclin1、MAP1LC3A的表达及抑制肿瘤干细胞标志物CD133的表达有关.

关 键 词:蝎毒多肽提取物  S180肉瘤  自噬  肿瘤干细胞  雷帕霉素
收稿时间:8/5/2014 12:00:00 AM

Inhibitory mechanism of polypeptide extract from scorpion venom on sarcoma S180 by promoting autophagy
ZHANG Lu-lu,ZHAGN Wei-dong,WU Li-cun,ZHANG Yue-ying,WANG Zhao-peng,WANG Zhao-xi,JIA Qing and ZHAO Qian-qian.Inhibitory mechanism of polypeptide extract from scorpion venom on sarcoma S180 by promoting autophagy[J].Chinese Traditional and Herbal Drugs,2015,46(8):1190-1194.
Authors:ZHANG Lu-lu  ZHAGN Wei-dong  WU Li-cun  ZHANG Yue-ying  WANG Zhao-peng  WANG Zhao-xi  JIA Qing and ZHAO Qian-qian
Institution:Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Department of Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China;School of Medicine and Life Sciences, University of Jinan-Shandong, Academy of Medical Sciences, Jinan 250062, China;Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Department of Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China;Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Department of Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China;Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Department of Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China;Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Department of Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China;Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Department of Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China;Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Department of Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China;Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Department of Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China;School of Medicine and Life Sciences, University of Jinan-Shandong, Academy of Medical Sciences, Jinan 250062, China
Abstract:Objective To explore the inhibitory mechanism of polypeptide extract from scorpion venom (PESV) on sarcoma S180. Methods Thirty mice were implanted with S180 cells and randomly divided into three groups: control group, PESV group, and rapamycin (RAPA) group with 10 mice in each group. Then the tumor volume growth curve was drawn and the tumor inhibitory rate (IR) was calculated. The morphological changes of the tumor tissue were observed by HE staining. The protein expression levels of Beclin1, MAP1LC3A, and CD133 were detected using immunohistochemical assay. Western blotting was applied to detecting the expression of Beclin1, MAP1LC3A, and CD133 in tumor tissue of mice in each group. Results The growth of sarcoma S180 transplanted tumor was inhibited more obviously in the PESV group and RAPA group than that in the control group. The IR in the PESV and RAPA groups were 17.9% and 25.0%, respectively (P <0.05). Compared with the control group, the protein expression of Beclin1and MAP1LC3A increased while the protein expression of CD133 decreased (P <0.05). Conclusion PESV can inhibit the growth of sarcoma S180, the mechanisms might be associated with promoting the expression of autophagic relative factors, Beclin1 and MAP1LC3A as well as inhibiting the expression of CD133.
Keywords:polypeptide extract from scorpion venom  sarcoma S180  autophagy  tumor stem cells  rapamycin
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号